Regeneron spent $5 billion repurchasing shares from Sanofi in May 2020 and $900 million repurchasing global rights to Libtayo in July 2022, yet a windfall from sales of its Covid antibody cocktail as ...
--Traded as high as $430.58; highest intraday level since Sept. 27, 2024, when it hit $431.85 --Up 2.82% at today's intraday high; largest intraday percent increase since May 1, 2024, when it rose as ...
Front Month Nymex Natural Gas for Nov. delivery lost 0.10 cent per million British thermal units, or 0.04% to $2.3110 per million British thermal units today --Off 35.36% from its 52-week high of ...
CSX said it reached tentative five-year collective bargaining agreements with workers represented by two unions and another union ratified its latest contract.
The City of Cleveland, Ohio Water Revenue Bonds Series HH, 2024 have maturities ranging from 2026 to 2054. Bonds due in 2034 have an interest rate of 5%, a yield of 3.01% after it priced at 115.838, ...
--Off 15.06% from its record high of $5.119 hit Tuesday, May 21, 2024 --Month-to-date it is down 3.29% --Year-to-date it is up 46.75 cents or 12.05% All prices are calculated based on the settlement ...
We think Sherwin-Williams has a sound capital structure, and its consistent free cash flow generation should easily support its debt service requirements and future capital allocation decisions.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
Daniel Loeb's Third Point hedge fund told investors this month that it expected a Trump victory and that the outcome would boost U.S. stock markets. Trump's "America First" policy positions would ...
Thirteen of the last 15 U.S. presidents have presided over annualized total returns of between 10% and 17% for the S&P 500, he added. The S&P 500 performed in an "even tighter" range of 14% to 17% ...
Be Bio said it raised $82 million in a funding round which included participation from Bristol Myers Squibb and Takeda Ventures. Other participants in the round included Arch Venture Partners, Atlas ...
This figure drops to just 9% of three years, a period that fully captures the headwinds facing thematic funds since early ...